Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included coverage from the 59th American Society of Hematology Annual Meeting and Exposition; recommendations on the use of diabetes drugs with cardiovascular indications; and a new study found that despite changes in insurance plans to give consumers more clout, unnecessary medical spending remains a problem.
Read more about the stories in this podcast:
What We're Reading: Medical Device Approval; Medical Laboratories Sue Government; ACA Sign-Up Deadline: www.ajmc.com/newsroom/what-were-reading-medical-device-approval-medical-laboratories-sue-government-aca-signup-deadline
CAR T Progress: Global Submissions for Kymriah, 42% Ongoing Response With Yescarta in ZUMA-1 Patients: www.ajmc.com/conferences/ash-2017/car-t-progress-global-submissions-for-kymriah-42-ongoing-response-with-yescarta-in-zuma1-patients-
Dr Stephen Schuster Outlines CAR T Results Seen in Leukemia, Lymphoma, and Myeloma: www.ajmc.com/conferences/ash-2017/dr-stephen-schuster-outlines-car-t-results-seen-in-leukemia-lymphoma-and-myeloma
American Society of Hematology coverage: www.ajmc.com/conferences/ash-2017
ADA 2018 Standards Address Drugs With CV Benefits, Hold Firm on Blood Pressure: www.ajmc.com/newsroom/ada-2018-standards-address-drugs-with-cv-benefits-hold-firm-on-blood-pressure
Impact of Consumer-Directed Health Plans on Low-Value Healthcare: www.ajmc.com/journals/issue/2017/2017-vol23-n12/impact-of-consumerdirected-health-plans-on-lowvalue-healthcare